For citations:
Plugar A.K., Severskaya N.V., Isaev P.A., Panaseykin Yu.A., Polkin V.V., Vatina L.N., Agababyan T.A., Ivanov S.А., Kaprin A.D. Selpercatinib – a new option for a precision approach to the treatment of medullary thyroid cancer. Head and Neck Tumors (HNT). 2024;14(4):77-85. (In Russ.) https://doi.org/10.17650/2222-1468-2024-14-4-77-85
Email this article 